Cancer medicine unlocks the softer death for TB Culprit

A medication for cancer treatment currently in clinical trials could strengthen tuberculosis therapy by triggering a more controlled cell death process, which potentially reduces pulmonary damage in survivors, according to medicine researchers Johns Hopkins. The Navitoclax experimental medicine, when added to standard tuberculosis (TB) treatments, helped infected cells through a controlled process called apoptosis instead…

Read More

WMO: Update on anomalies 2023/4

The WMO launched its annual (now) STate of the Climate Report this week. As well as the (now) standard set of graphics related to Increased greenhouse gas concentrations, Increasing temperaturesReduction of glacier mass, etc., Zeke Hausfather and I wrote a brief synthesis about contributions to recent temperature anomalies. Readers will remember our"https://www.realclimate.org/index.php/archives/2024/05/new-journal-nature-2023/" Title ="Nuevo Diario:…

Read More

The last word about nothing

The prognosis for Friday above five thousand feet required more than a snowfoot, strong winds and temperatures well below freezing. So serious were the models that the National Meteorological Service had issued a winter storm warning for much of the southern Washington waterfalls, and around Mount Hood in Oregon. “Why are you going to go…

Read More